Antitrust Antitrust

Alliance Healthcare continues to defend UK antitrust charges over drug deals (correct*)

By Simon Zekaria
  • 24 Mar 2021 10:55
  • 25 Mar 2021 08:13
Alliance Healthcare "continues to defend" itself against UK charges of infringing competition law in deals to acquire the antibiotic Nitrofurantoin, according to a US securities filing submitted by AmerisourceBergen, which plans to buy Alliance.

AmerisourceBergen agreed in January to acquire the majority of Alliance Healthcare from peer Walgreens Boots Alliance for

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News